Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 7;16(8):18474-506.
doi: 10.3390/ijms160818474.

Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands

Affiliations
Review

Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands

Zdzisław Chilmonczyk et al. Int J Mol Sci. .

Abstract

Serotonin (5-HT) is a monoamine neurotransmitter that plays an important role in physiological functions. 5-HT has been implicated in sleep, feeding, sexual behavior, temperature regulation, pain, and cognition as well as in pathological states including disorders connected to mood, anxiety, psychosis and pain. 5-HT1A receptors have for a long time been considered as an interesting target for the action of antidepressant drugs. It was postulated that postsynaptic 5-HT1A agonists could form a new class of antidepressant drugs, and mixed 5-HT1A receptor ligands/serotonin transporter (SERT) inhibitors seem to possess an interesting pharmacological profile. It should, however, be noted that 5-HT1A receptors can activate several different biochemical pathways and signal through both G protein-dependent and G protein-independent pathways. The variables that affect the multiplicity of 5-HT1A receptor signaling pathways would thus result from the summation of effects specific to the host cell milieu. Moreover, receptor trafficking appears different at pre- and postsynaptic sites. It should also be noted that the 5-HT1A receptor cooperates with other signal transduction systems (like the 5-HT1B or 5-HT2A/2B/2C receptors, the GABAergic and the glutaminergic systems), which also contribute to its antidepressant and/or anxiolytic activity. Thus identifying brain specific molecular targets for 5-HT1A receptor ligands may result in a better targeting, raising a hope for more effective medicines for various pathologies.

Keywords: antidepressant activity; receptor trafficking; serotonin 1A receptors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Raphe neurons with low (A) and high (B) 5-HT1A receptor density. Mice with high somatodendritic 5-HT1A expression have lower basal firing rate (and elevated behavioral despair level). Blue dots—serotonin, red shape—SERT, green shape—5-HT1A receptor (according to [13,14]).
Figure 2
Figure 2
Signal transduction pathways of the 5-HT1A receptor [22,23,24].
Figure 3
Figure 3
Main elements of the receptor tyrosine kinase pathway.
Figure 4
Figure 4
Pharmacological profile (pEC50 for cAMP inhibition and ERK1/2 phosphorylation on the Y axis) of F15599 (brown), F13714 (green), and 5-HT (dark blue) [55].
Figure 5
Figure 5
Adult 5-HT raphe-PFC circuitry in anxiety and depression model (according to Albert et al.) [161]. The model shows 5-HT neurons (brown) projecting to prefrontal cortex GABAergic interneurons (yellow) and glutamatergic pyramidal neurons (blue) with transmitter release illustrated as small circles of the same colors. Receptors: 5-HT1A (green), 5-HT2A (light green), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-glutamate (purple) and GABAA receptors (blue). The response in the target neurons (red ovals): stimulatory (+), inhibitory (−). (↑)—elevation, (↓)—decrease. 5-HT1A heteroreceptors and GABAA receptors reduce the activity of the pyramidal neurons while 5-HT2A receptors activate the neurons.
Figure 6
Figure 6
The potential mechanism underlying the augmenting effects of 5-HT2A receptor blockade. (A) Increased extracellular 5-HT concentration may activate limbic monoamine system; (B) Blockade of activating 5-HT2A receptors may reduce a potential hyperactivity of the monoamine system (according to [2]).

Similar articles

Cited by

References

    1. Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., Grewal J.S., Garnovskaya M.N. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol. Ther. 2001;92:179–212. - PubMed
    1. Artigas F. Developments in the field of antidepressants, where do we go now? Eur. Neuropsychopharmacol. 2015;25:657–670. - PubMed
    1. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992;72:165–229. - PubMed
    1. Artigas F. Serotonin receptors involved in antidepressant effects. Pharmacol. Ther. 2013;137:119–131. - PubMed
    1. Adell A., Celada P., Abellan M.T., Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Brain Res. Rev. 2002;39:154–180. - PubMed

Publication types

MeSH terms

LinkOut - more resources